<DOC>
	<DOCNO>NCT01158573</DOCNO>
	<brief_summary>The purpose study examine whether high level cysteinyl leukotrienes obese subject non-obese subject . Cysteinyl leukotrienes pro-inflammatory substance cause asthma narrow airway lung . The investigator want see subject increase fat store therefore increase leptin , fat-related protein regulate leukotrienes , increased level leukotrienes blood , lung urine . The investigator would also like determine relationship cysteinyl leukotrienes exhale nitric oxide level asthmatic without obesity . Nitric oxide anti-inflammatory suppresses leukotriene synthesis .</brief_summary>
	<brief_title>Role Cysteinyl Leukotrienes Pathogenesis Asthma Obesity</brief_title>
	<detailed_description>This cross-sectional observational study characterize association obese asthmatic inflammatory mediator cysteinyl leukotrienes . Our hypothesis alter adipokine level obesity result augment cysteinyl leukotriene synthesis play significant role pathogenesis asthma subject .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Cysteinyl-leukotriene</mesh_term>
	<criteria>1865 yr old adult asthma , nonsmoking least one year Healthy nonsmoking adult , age 1865 without asthma Heavy subject BMI &gt; 30 kg/m2 Subjects normal weight ( BMI 2025 kg/m2 ) Subject take antileukotriene therapy ( Singulair , Accolate , Zyflo ) No chronic oral steroid use No recent history infection No recent history flare lung disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Obesity</keyword>
</DOC>